Stephanie A. Amiel
St Bartholomew's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephanie A. Amiel.
Clinical Endocrinology | 1988
Jeffrey M P Holly; R A Biddlecombe; David B. Dunger; J. A. Edge; Stephanie A. Amiel; R. J. S. Howell; Tim Chard; Lesley H. Rees; J. A. H. Wass
Evidence is accumulating that a non‐GH dependent insulin‐like growth factor‐binding protein (IGF‐BP) is not only a carrier protein but also has an active role in the growth process.
Clinical Endocrinology | 1993
Andrew M. Cotterill; Jeffrey M P Holly; Stephanie A. Amiel; J. A. H. Wass
OBJECTIVES Recent animal studies have suggested that insulin‐like growth factor binding protein (IGFBP)‐1 may regulate the insulin‐like actions of the circulating IGFs. In man, IGFBP‐1 levels change rapidly with nutritional status and are inversely related to changes in insulin. In‐vitro studies have shown that both insulin and glucose independently regulate IGFBP‐1 secretion in an inverse manner. A rapid rise of serum IGFBP‐1 levels following insulin‐induced hypoglycaemia suggested that glucose or glucose availability, rather than insulin, may be the major regulator of IGFBP‐1.
Biotechnology in Growth Regulation | 1989
Jeffrey M P Holly; David B. Dunger; Julie Edge; C. P. Smith; Stephanie A. Amiel; R A Biddlecombe; Martin O. Savage; J. A. H. Wass
Publisher Summary This chapter describes the insulin-dependence of the small IGF-binding protein (IGF-SBP). Evidence is accumulating that the IGF-SBP may be an important acute modulator of IGF activity. The relationship within individuals was examined in profiles of IGF-SBP and insulin measured over 12 or 24 h periods in 14 normal subjects and in 11 adolescents with diabetes mellitus. In 5 of the diabetics overnight profiles were repeated with euglycaemia maintained with a glucose clamp. The relationship between individuals was studied in a cross-sectional study of 116 normal subjects in whom fasting levels of IGF-SBP and insulin were measured. IGF-SBP was measured with a specific RIA. The IGF-SBP was shown to be closely inversely related to insulin in both normals and subjects with diabetes mellitus. In the diabetics IGF-SBP levels were generally high consistent with the insulin deficiency. Very high concentrations were observed in poorly controlled subjects, although a simple relationship with the level of acute metabolic control could not be established. In puberty the rise in IGF-I is accompanied by a rise in insulin and a fall in IGF-SBP.
Clinical Science | 1991
Stephanie A. Amiel; Helen Archibald; Gary D Chusney; A. J. K. Williams; Edwin Gale
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies
Archive | 2011
John Wass; Paul M. Stewart; Stephanie A. Amiel; Melanie C. Davies